Kümpfel T - Search Results

1

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O. Warnke C, et al. Among authors: kumpfel t. Ann Neurol. 2014 Dec;76(6):792-801. doi: 10.1002/ana.24153. Epub 2014 May 8. Ann Neurol. 2014. PMID: 24729444 Free PMC article.

2

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.

Ziemssen T, Kümpfel T, Klinkert WE, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: kumpfel t. Brain. 2002 Nov;125(Pt 11):2381-91. doi: 10.1093/brain/awf252. Brain. 2002. PMID: 12390966

3

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.

Krumbholz M, Pellkofer H, Gold R, Hoffmann LA, Hohlfeld R, Kümpfel T. Krumbholz M, et al. Among authors: kumpfel t. Arch Neurol. 2007 Sep;64(9):1331-3. doi: 10.1001/archneur.64.9.1331. Arch Neurol. 2007. PMID: 17846274

4

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Obermeier B, Mentele R, Malotka J, Kellermann J, Kümpfel T, Wekerle H, Lottspeich F, Hohlfeld R, Dornmair K. Obermeier B, et al. Among authors: kumpfel t. Nat Med. 2008 Jun;14(6):688-93. doi: 10.1038/nm1714. Epub 2008 May 18. Nat Med. 2008. PMID: 18488038

5

Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.

Kümpfel T, Hohlfeld R. Kümpfel T, et al. Nat Rev Neurol. 2009 Oct;5(10):528-9. doi: 10.1038/nrneurol.2009.154. Nat Rev Neurol. 2009. PMID: 19794511

6

[Progress of therapy in patients with multiple sclerosis].

Kümpfel T, Havla J, Hohlfeld R. Kümpfel T, et al. MMW Fortschr Med. 2010 Mar 4;152(9):42-4. MMW Fortschr Med. 2010. PMID: 20384096 German. No abstract available.

7

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.

Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL, Hohlfeld R, Kümpfel T. Havla J, et al. Among authors: kumpfel t. J Neurol. 2011 Sep;258(9):1665-9. doi: 10.1007/s00415-011-5996-y. Epub 2011 Mar 23. J Neurol. 2011. PMID: 21431380

8

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.

Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Brück W. Metz I, et al. Among authors: kumpfel t. Acta Neuropathol. 2012 Feb;123(2):235-45. doi: 10.1007/s00401-011-0900-5. Epub 2011 Nov 6. Acta Neuropathol. 2012. PMID: 22057786 Free PMC article.

9

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group. Kleiter I, et al. Among authors: kumpfel t. Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216. Arch Neurol. 2012. PMID: 22332191

10

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Havla JB, Pellkofer HL, Meinl I, Gerdes LA, Hohlfeld R, Kümpfel T. Havla JB, et al. Among authors: kumpfel t. Arch Neurol. 2012 Feb;69(2):262-4. doi: 10.1001/archneurol.2011.1057. Arch Neurol. 2012. PMID: 22332194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters